Cytokine Release Syndrome and Associated Acute Toxicities in Pediatric Patients Undergoing Immune Effector Cell Therapy or Hematopoietic Cell Transplantation

被引:13
作者
Baumeister, Susanne H. C. [1 ,2 ,3 ]
Mohan, Gopi S. [1 ,3 ,4 ]
Elhaddad, Alaa [5 ]
Lehmann, Leslie [1 ,2 ,3 ]
机构
[1] Boston Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA
[2] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA
[3] Harvard Med Sch, Boston, MA 02115 USA
[4] Massachusetts Gen Hosp, Div Pediat Crit Care, Boston, MA 02114 USA
[5] Childrens Canc Hosp Egypt, Natl Canc Inst Cairo, Cairo, Egypt
关键词
cytokine release syndrome (CRS); immune effector cell associated neurotoxicity syndrome (ICANS); immune effector cells (IEC); CAR T cells; blinatumomab; pediatric hematopoietic cell transplantation (HCT); haploidentical cell transplantation (Haplo-HCT); ACUTE LYMPHOBLASTIC-LEUKEMIA; RECEPTOR T-CELLS; TERM-FOLLOW-UP; FREE SURVIVAL; YOUNG-ADULTS; BLINATUMOMAB; MANAGEMENT; CHILDREN; TOCILIZUMAB; GUIDELINES;
D O I
10.3389/fonc.2022.841117
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Immune effector cells (IEC) are a powerful and increasingly targeted tool, particularly for the control and eradication of malignant diseases. However, the infusion, expansion, and persistence of autologous or allogeneic IEC or engagement of endogenous immune cells can be associated with significant systemic multi-organ toxicities. Here we review the signs and symptoms, grading and pathophysiology of immune-related toxicities arising in the context of pediatric immunotherapies and haploidentical T cell replete Hematopoietic Cell Transplantation (HCT). Principles of management are discussed with particular focus on the intersection of these toxicities with the requirement for pediatric critical care level support.
引用
收藏
页数:16
相关论文
共 85 条
[1]   Cytokine release syndrome after haploidentical hematopoietic cell transplantation: an international multicenter analysis [J].
Abboud, Ramzi ;
Wan, Fei ;
Mariotti, Jacopo ;
Arango, Marcos ;
Castagna, Luca ;
Romee, Rizwan ;
Hamadani, Mehdi ;
Chhabra, Saurabh .
BONE MARROW TRANSPLANTATION, 2021, 56 (11) :2763-2770
[2]   Severe Cytokine-Release Syndrome after T Cell-Replete Peripheral Blood Haploidentical Donor Transplantation Is Associated with Poor Survival and Anti-IL-6 Therapy Is Safe and Well Tolerated [J].
Abboud, Ramzi ;
Keller, Jesse ;
Slade, Michael ;
DiPersio, John F. ;
Westervelt, Peter ;
Rettig, Michael P. ;
Meier, Stephanie ;
Fehniger, Todd A. ;
Abboud, Camille N. ;
Uy, Geoffrey L. ;
Vij, Ravi ;
Trinkaus, Kathryn M. ;
Schroeder, Mark A. ;
Romee, Rizwan .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (10) :1851-1860
[3]  
Ahmed S, 2020, J CLIN ONCOL, V38
[4]   Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T) [J].
Alvi, Raza M. ;
Frigault, Matthew J. ;
Fradley, Michael G. ;
Jain, Michael D. ;
Mahmood, Syed S. ;
Awadalla, Magid ;
Lee, Dae Hyun ;
Zlotoff, Daniel A. ;
Zhang, Lili ;
Drobni, Zsofia D. ;
Hassan, Malek Z. O. ;
Bassily, Emmanuel ;
Rhea, Isaac ;
Ismail-Khan, Roohi ;
Mulligan, Connor P. ;
Banerji, Dahlia ;
Lazaryan, Aleksandr ;
Shah, Bijal D. ;
Rokicki, Adam ;
Raje, Noopur ;
Chavez, Julio C. ;
Abramson, Jeremy ;
Locke, Frederick L. ;
Neilan, Tomas G. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (25) :3099-3108
[5]  
[Anonymous], Highlights of prescribing information
[6]   Description of neurotoxicity in a series of patients treated with CAR T-cell therapy [J].
Belin, Catherine ;
Devic, Perrine ;
Ayrignac, Xavier ;
Dos Santos, Amelie ;
Paix, Adrien ;
Sirven-Villaros, Lila ;
Simard, Claire ;
Lamure, Sylvain ;
Gastinne, Thomas ;
Ursu, Renata ;
Berger, Colette ;
Platon, Laura ;
Tessoulin, Benoit ;
Azoulay, Elie ;
Wallet, Florent ;
Thieblemont, Catherine ;
Bachy, Emmanuel ;
Cartron, Guillaume ;
Laplaud, David A. ;
Carpentier, Antoine F. .
SCIENTIFIC REPORTS, 2020, 10 (01)
[7]   Part 13: Pediatric Basic Life Support 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care [J].
Berg, Marc D. ;
Schexnayder, Stephen M. ;
Chameides, Leon ;
Terry, Mark ;
Donoghue, Aaron ;
Hickey, Robert W. ;
Berg, Robert A. ;
Sutton, Robert M. ;
Hazinski, Mary Fran .
CIRCULATION, 2010, 122 (18) :S862-S875
[8]   Immune Effector Cell Associated Neurotoxicity (ICANS) in Pediatric and Young Adult Patients Following Chimeric Antigen Receptor (CAR) T-Cell Therapy: Can We Optimize Early Diagnosis? [J].
Brown, Brandon Douglas ;
Tambaro, Francesco Paolo ;
Kohorst, Mira ;
Chi, Linda ;
Mahadeo, Kris Michael ;
Tewari, Priti ;
Petropoulos, Demetrios ;
Slopis, John M. ;
Sadighi, Zsila ;
Khazal, Sajad .
FRONTIERS IN ONCOLOGY, 2021, 11
[9]   Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia A Randomized Clinical Trial [J].
Brown, Patrick A. ;
Ji, Lingyun ;
Xu, Xinxin ;
Devidas, Meenakshi ;
Hogan, Laura E. ;
Borowitz, Michael J. ;
Raetz, Elizabeth A. ;
Zugmaier, Gerhard ;
Sharon, Elad ;
Bernhardt, Melanie B. ;
Terezakis, Stephanie A. ;
Gore, Lia ;
Whitlock, James A. ;
Pulsipher, Michael A. ;
Hunger, Stephen P. ;
Loh, Mignon L. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (09) :833-842
[10]   Practical guidelines for monitoring and management of coagulopathy following tisagenlecleucel CAR T-cell therapy [J].
Buechner, Jochen ;
Grupp, Stephan A. ;
Hiramatsu, Hidefumi ;
Teachey, David T. ;
Rives, Susana ;
Laetsch, Theodore W. ;
Yanik, Gregory A. ;
Wood, Patricia ;
Awasthi, Rakesh ;
Yi, Lan ;
Chassot-Agostinho, Andrea ;
Eldjerou, Lamis K. ;
De Moerloose, Barbara .
BLOOD ADVANCES, 2021, 5 (02) :593-601